Physician

Mohamed H Khan, M.D.

According to 2025 Medicare claims, Mohamed Khan, M.D. (NPI: 1649230988) practices interventional cardiology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is MOHAMED H KHAN MD INC (NPI: 1144262593; TIN: 20-2550697) and primary practice location at 96001-3026.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,686 traditional Medicare patients, billed 38,741 HCPCS/CPT codes, and received $5,416,625 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 25,643 prescription claims across 4,159 beneficiaries totaling $8,039,431 in drug costs, led by Eliquis (Apixaban). DME data shows 206 claims. Open Payments data shows 113 records totaling $97,662. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $3,026,353 to $5,416,625. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,202,075 to $8,039,431. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $159,322 to $79,279.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.1M$6.2M2015 Medicare payment: $3,026,353 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,823,024 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,077,585 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,613,443 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,151,259 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,665,006 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,374,883 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,647,575 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,667,366 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,416,625 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155,71835,789$3,026,353
20165,04534,101$2,823,024
20174,80232,198$3,077,585
20185,04335,064$3,613,443
20196,23141,511$6,151,259
20205,62136,352$5,665,006
20215,54734,711$5,374,883
20226,17537,259$5,647,575
20236,50540,460$5,667,366
20246,68638,741$5,416,625

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.0M$8.0M2015 Drug cost: $2,202,075 (USD; Tot_Drug_Cst)2016 Drug cost: $2,722,408 (USD; Tot_Drug_Cst)2017 Drug cost: $3,083,856 (USD; Tot_Drug_Cst)2018 Drug cost: $3,162,695 (USD; Tot_Drug_Cst)2019 Drug cost: $3,817,379 (USD; Tot_Drug_Cst)2020 Drug cost: $4,570,731 (USD; Tot_Drug_Cst)2021 Drug cost: $5,277,408 (USD; Tot_Drug_Cst)2022 Drug cost: $6,470,619 (USD; Tot_Drug_Cst)2023 Drug cost: $7,706,283 (USD; Tot_Drug_Cst)2024 Drug cost: $8,039,431 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152,17921,890$2,202,075
20162,19321,564$2,722,408
20172,15819,553$3,083,856
20182,33618,763$3,162,695
20192,80621,487$3,817,379
20202,87020,894$4,570,731
20213,03421,069$5,277,408
20223,38521,667$6,470,619
20233,74523,248$7,706,283
20244,15925,643$8,039,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$118K$236K2015 Medicare payment: $151,463 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $156,726 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $178,854 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $141,873 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $138,480 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $198,973 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $235,667 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $185,356 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $87,639 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $77,062 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151541,229$151,463
20161451,163$156,726
2017136871$178,854
2018109882$141,873
2019110843$138,480
202091741$198,973
202184564$235,667
202260386$185,356
202338316$87,639
202426206$77,062

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function3,0713,170$153
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2,0882,667$91
93015Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician2,1962,222$58
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report3,4474,825$10
J2785Injection, regadenoson, 0.1 mg1,7837,140$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban2,431180,828$3,488,873
EntrestoSacubitril/Valsartan92766,687$1,430,676
XareltoRivaroxaban69150,456$923,626
JardianceEmpagliflozin42931,131$575,969
Repatha SureclickEvolocumab36722,030$411,962

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0606Automatic external defibrillator, with integrated electrocardiogram analysis, garment typeY1228$66,673
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY14120$9,155
K0738Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R23$714
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R35$519

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.97$34,688AngioDynamics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.16$62,974Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohamed H. Khan, M.D.?

Tedicare shows public-source Medicare data for Mohamed H. Khan, M.D. (NPI 1649230988), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed H. Khan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohamed H. Khan, M.D.?

Mohamed H. Khan, M.D. is linked to MOHAMED H KHAN MD INC (billing NPI 1144262593) in the available physician profile data.

Does Mohamed H. Khan, M.D. have Open Payments data?

Mohamed H. Khan, M.D. has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.